Back
Canopy Growth Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
35
CGC
Canopy Growth
Last Price:
9.05
Seasonality Move:
-10.38%
Sell
48
AUPH
Aurinia Pharmaceuticals
Last Price:
5.03
Seasonality Move:
3.33%
Sell
35
Canopy Growth (CGC)
is a Sell
Is Canopy Growth a Buy, Sell or Hold?
- The current Canopy Growth [CGC] share price is $9.05. The Score for CGC is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- CGC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $5.02. The Score for AUPH is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- AUPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CGC Stock Price Chart
What is Canopy Growth's stock price today?
-
The Canopy Growth share price today is $9.05
The current trend is moderately bearish and CGC is experiencing selling pressure, which indicates risk of future bearish movement.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $5.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUPH is experiencing selling pressure, which indicates risk of future bearish movement.
CGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.63 | Buy |
Relative Strength Index (14 RSI): | 50.59 | Buy |
Chaikin Money Flow: | -6727868 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.38 - 10.7) | Buy |
Bollinger Bands (100): | (3.28 - 8.36) | Buy |
AUPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 45.08 | Sell |
Chaikin Money Flow: | -1187685 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.95 - 5.15) | Sell |
Bollinger Bands (100): | (4.92 - 8.06) | Sell |
CGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.9 | Sell |
20-day SMA: | 9.09 | Sell |
50-day SMA: | 7.23 | Buy |
200-day SMA: | 6.1 | Buy |
8-day EMA: | 9.63 | Sell |
20-day EMA: | 9.27 | Sell |
50-day EMA: | 7.87 | Buy |
200-day EMA: | 8.36 | Buy |
AUPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.14 | Sell |
20-day SMA: | 5.04 | Sell |
50-day SMA: | 5.14 | Sell |
200-day SMA: | 7.58 | Sell |
8-day EMA: | 5.1 | Sell |
20-day EMA: | 5.09 | Sell |
50-day EMA: | 5.41 | Sell |
200-day EMA: | 7.15 | Sell |
Canopy Growth Earnings Growth & CGC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.01 per share, an increase this year of $6.78 per share, and an increase next year of $1.55 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.35 per share.
Canopy Growth Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aurinia Pharmaceuticals Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |